Uri A. Lopatin - Dec 23, 2021 Form 3 Insider Report for PARDES BIOSCIENCES, INC. (PRDS)

Role
President and CEO, Director
Signature
/s/ Elizabeth Lacy, attorney-in-fact
Stock symbol
PRDS
Transactions as of
Dec 23, 2021
Transactions value $
$0
Form type
3
Date filed
12/27/2021, 04:31 PM
Next filing
Feb 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding PRDS Common Stock 5.33M Dec 23, 2021 Direct
holding PRDS Common Stock 352K Dec 23, 2021 See footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person and his spouse are co-trustees of the Lopatin Descendants' Trust (the "Trust"). The Reporting Person disclaims Section 16 beneficial ownership of the securities held by the Trust, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 or any other purpose.

Remarks:

Exhibit 24 - Power of Attorney Effective immediately following the effective time of the merger pursuant to that certain Agreement and Plan of Merger dated as of June 29, 2021, as amended, by and among Pardes Biosciences Sub, Inc. (f/k/a Pardes Biosciences, Inc.), Issuer (f/k/a FS Development Corp. II), and certain other parties thereto, the reporting person became a director and an officer of the Issuer.